COMP <GO>
APMD vs GYRE // ENTERPRISE SCALE & MARKET CAP
Apnimed Inc. (NASDAQ) VS. Gyre Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: APMD 1
— GYRE 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: APMD
LAST: $16.40 (-5.42%) • MKT CAP: $721.9M
market-cap
$721.9M
LAST: $4.56 (-28.94%) • MKT CAP: $714.8M
market-cap
$714.8M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (APMD VS. GYRE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | APMD | GYRE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 95.40% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 25.40% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 53.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -0.03% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | 9.90% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 8.50% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 10.20% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 14.33 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 5/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.3 | 49.8 | -9.50 | GYRE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 67.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $721.9M | $714.8M | $7.1M | APMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | APMD REV | GYRE REV | APMD GROSS % | GYRE GROSS % | APMD FCF | GYRE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $116.6M | — | 95.4% | — | -$180.0K |
| FY 2024 | — | $105.8M | — | 96.3% | — | -$6.0M |
| FY 2023 | — | $113.5M | — | — | — | $25.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
APMD // BETA —
GYRE // BETA —